凯发天生赢家一触即发首页

    Lentiviral vector

    Lentiviral vector

    Lentiviral vectors are viral vector systems modified from HIV-1 that can effectively integrate exogenous genes or exogenous shRNAs into the host chromosome, thereby achieving persistent expression of the target sequence. Lentivirals have become one of the commonly used vector forms for expressing exogenous genes or exogenous shRNAs and are gaining increasingly widespread application. CellValley can provide customized lentiviral vector services targeting various tumor targets, such as BCMA, CD19, CD38, CD22, EGFR/EGFRVIII, etc.
    Description

    Highlights

     Lentiviral  vectors possess characteristics such as broad host range, low immunogenicity, large gene capacity, and long-term expression . They can effectively infect various cell types , including cultured tumor cells, hepatocytes, cardiomyocytes, neurons, endothelial cells, and stem cells. Lentiviral infection exhibits integration properties, effectively integrating exogenous genes into the host chromosome for persistent expression, thus enabling the construction of stable cell lines for gene function studies. Modifying T cells using lentiviral vectors can be used for CAR-T cell therapy.
     Lentivirals  have high safety profiles  and  have not been found to be pathogenic. Lentiviral vectors can be used to modify T cells and NK cells for the preparation of CAR-T and CAR-NK cell therapy products.  Lentivirals have low immunogenicity does not easily induce an immune response, making them suitable for animal experiments.

    Overview

     Lentiviruses  are a type of viral vector modified from human immunodeficiency virus (HIV). They are a type of retrovirus with an RNA genome. Their virulence genes have been knocked out and replaced by exogenous target genes. Belonging to the pseudovirus family , they can integrate exogenous genes into their genome for stable expression and can infect both dividing and non-dividing cells. After entering the cell, the lentiviral genome  is reverse transcribed into DNA in the cytoplasm, forming a pre-integration DNA complex. Upon entering the nucleus, the DNA integrates into the cell genome. The integrated DNA is transcribed into mRNA, returns to the cytoplasm, and expresses the target protein or produces small RNA. Lentivirus- mediated gene expression or small RNA interference is persistent and stable, and occurs with cell division (Figure 1).

      Figure 1. The process of lentivirus packaging and cell infection.


    About Us
    Scan to follow our latest newsScan to follow our latest news
    Contact Us
    400-800-1266

    Working hours: Monday to Friday, 9:00-18:00

    Contact:Ms. Lai

    Email:laijiaqi@aicaocy.com

    Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

    Bottom Navigation
    Shenzhen Cell Valley Biopharmaceutical Co., Ltd.​​ is a comprehensive one-stop outsourcing service provider in China focused on the cell and gene therapy industry. It is also one of the first CRO/CDMO companies in the country to possess GMP industrial production capabilities for clinical-grade retroviral vectors . The company is a major public technical service platform construction project for CRO/CDMO in Shenzhen and is included among the city's latest announced "20+8" strategic emerging industry projects.Shenzhen Cell Valley has the capability for standardized and industrialized production of GMP-grade cell products such as CAR-T cells. Its primary production lines include those for various cell products like CAR-T, CAR-NK, CAR-M, γδT, TIL, and TCR-T. Additionally, the company operates production lines for various viral vectors, including RVV, LVV, non-viral vectors, and AAV, as well as for cellular raw materials used in producing therapeutics such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses, and vaccines.
     Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software